University of Southern California


Ming Hsieh Institute for Research on Engineering-Medicine for Cancer

Program Overview

The Hsieh Institute aims to make USC a national and international leader in translational cancer research that bridges basic science, engineered devices, synthesized molecules and materials, and medicine. Established in 2010 through a generous gift from Ming Hsieh (a USC graduate of the Viterbi School of Engineering and founder of Cogent Systems), the centerpiece of the Hsieh Institute will be integrated engineering, scientific and medical research that speeds discovery and creates the pathways by which research rapidly improves the lives of patients with cancer. By embarking on this new interdisciplinary direction, we aim to develop new therapeutic approaches to cancer patients that minimize the adverse effects typically associated with conventional chemotherapeutic agents.

The Ming Hsieh Institute seeks proposals that will initiate new nanomedicine research projects that show exceptional promise for translation into clinical trials for treatment of cancer. Proposals should demonstrate that a modest seed investment will have significant impact, either through initiating a novel research concept, or accelerating research into clinical trials.

2016 MHI RFP (in progress)

Proposal Deadline: January 22, 2016, 5:00 pm

View Featured Research of previously awarded proposals.

Proposal Submission

Submit your proposal application utilizing the new Office of Research application submission and reporting portal.

Go to USC Application Portal to log in (or create an account for yourself), using your USC email address.

Important: You may experience problems with the online application if using the browser Internet Explorer. If you experience problems, it is advisable to access the application system through a different browser, such as Mozilla Firefox or Google Chrome.

For questions regarding the proposal submission process, please contact the Office of Research at ( or 213-821-8163).